Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"

Affiliations

¹ From Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (J.H.); Division of Cardiology, University of California at Los Angeles (E.H.Y.); University of Texas, MD Anderson Cancer Center, Houston (C.I.); Citizens Memorial Hospital, Bolivar, MO (K.M.); and University of Missouri, Columbia (K.M.).

Free article

Comment

Joerg Herrmann et al. Circulation. 2016.

Free article

. 2016 Nov 15;134(20):e466-e467.

doi: 10.1161/CIRCULATIONAHA.116.024415.

¹ From Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (J.H.); Division of Cardiology, University of California at Los Angeles (E.H.Y.); University of Texas, MD Anderson Cancer Center, Houston (C.I.); Citizens Memorial Hospital, Bolivar, MO (K.M.); and University of Missouri, Columbia (K.M.).

No abstract available

Comment on

Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.
Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Herrmann J, et al. Circulation. 2016 Mar 29;133(13):1272-89. doi: 10.1161/CIRCULATIONAHA.115.018347. Circulation. 2016. PMID: 27022039 Free PMC article. Review.
Letter by Gallucci and Storto Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue".
Gallucci G, Storto G. Gallucci G, et al. Circulation. 2016 Nov 15;134(20):e464-e465. doi: 10.1161/CIRCULATIONAHA.116.023449. Circulation. 2016. PMID: 27881501 No abstract available.